 | • レポートコード：QY20ST-09723 • 出版社/出版日：QYResearch / 2020年9月15日 ※2025年版があります。お問い合わせください。 • レポート形態：英文、PDF、141ページ • 納品方法：Eメール（受注後2~3営業日） • 産業分類：医薬品、医療 |
| Single User | ￥580,000 (USD4,000) | ▷ お問い合わせ |
| Multi User | ￥870,000 (USD6,000) | ▷ お問い合わせ |
| Enterprise License | ￥1,160,000 (USD8,000) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、世界の水痘生ワクチン市場について種類別（一価ワクチン、多価ワクチン）、用途別（Chicken Pox Immunization、 Herpes Zoster Immunization、 Measles Immunization、 Others）、地域別（北米、ヨーロッパ、中国、日本、東南アジア、インド）に区分して調査し、纏めました。2015年～2026年までの市場規模予測、主要プレイヤーの競争状況・市場シェア・企業情報、製造コスト分析、販売チャネル・流通業者・顧客情報、市場動向・機会・課題などのマーケットデータが記載されています。市場予測データは新型コロナウイルスの影響を反映させました。 ・水痘生ワクチン市場の概要 ・世界の主要地域別水痘生ワクチン市場規模2015-2026 ・主要プレイヤーの競争状況・市場シェア ・世界の水痘生ワクチン市場規模2015-2026：種類別（一価ワクチン、多価ワクチン） ・世界の水痘生ワクチン市場規模2015-2026：用途別（Chicken Pox Immunization、 Herpes Zoster Immunization、 Measles Immunization、 Others） ・水痘生ワクチンの北米市場規模2015-2020 ・水痘生ワクチンのヨーロッパ市場規模2015-2020 ・水痘生ワクチンの中国市場規模2015-2020 ・水痘生ワクチンの日本市場規模2015-2020 ・水痘生ワクチンの東南アジア市場規模2015-2020 ・水痘生ワクチンのインド市場規模2015-2020 ・主要プレイヤーの企業情報：事業概要・売上・企業動向 ・水痘生ワクチンの製造コスト分析 ・販売チャネル、流通業者、顧客 ・水痘生ワクチンの市場動向・機会・課題 ・調査の結論 |
A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data in a statistical manner. It examines the historic accomplishments and recent opportunities present in the global Varicella Live Vaccine market. QY Research report focuses on the consumption, geography, by type, by application, and the competitive landscape. The 4000 version of the report mainly splits the data for each region to analyze the leading companies, applications, and product types.
QY Research aims to provide a complete knowledgeable report so that the readers will benefit from it. The report is properly examined and compiled by industry experts and will shed light on the key information that requires from the clients.
Report Overview:
Since the COVID-19 virus outbreak in December 2019, the disease has spread to almost 100 countries around the globe with the World Health Organization declaring it a public health emergency. The global impacts of the coronavirus disease 2019 (COVID-19) are already starting to be felt, and will significantly affect the Varicella Live Vaccine market in 2020.
COVID-19 can affect the global economy in three main ways: by directly affecting production and demand, by creating supply chain and market disruption, and by its financial impact on firms and financial markets.
The outbreak of COVID-19 has brought effects on many aspects, like flight cancellations; travel bans and quarantines; restaurants closed; all indoor events restricted; over forty countries state of emergency declared; massive slowing of the supply chain; stock market volatility; falling business confidence, growing panic among the population, and uncertainty about future.
This report also analyses the impact of Coronavirus COVID-19 on the Varicella Live Vaccine industry.
Based on our recent survey, we have several different scenarios about the Varicella Live Vaccine YoY growth rate for 2020. The probable scenario is expected to grow by a xx% in 2020 and the revenue will be xx in 2020 from US$ 2361 million in 2019. The market size of Varicella Live Vaccine will reach xx in 2026, with a CAGR of xx% from 2020 to 2026.
QY Research report provides an overview and scope of the global Varicella Live Vaccine market, stating its drivers, trends, opportunities, and restraints. The report also comprises all key details of the global Varicella Live Vaccine market such as market strategies, sales volumes, and consumption. The report also covers the names of all distribution channels such as manufacturers, suppliers, wholesalers, distributors, consumers, and dealers.
QY Research also presents the statistical data in the form of infographics, tables, and charts to predict the trends and developments of the global Varicella Live Vaccine market over the forecast period. The research analysts have also used a framework such as key industry experts interview, research papers, refer journals, survey reports, and face-to-face interviews with expert professionals to know the detailed outlook of the global Varicella Live Vaccine market. The report also includes nautical information, where it shows Varicella Live Vaccine market product volume, utilization value, and production processes.
The research report also consists of a competitive landscape that describes the top players that are functioning in the global Varicella Live Vaccine market. This report also describes the key developments and trends, mergers and acquisitions strategies, and new product innovation that will show an enormous benefit to the companies that are competing in the global Varicella Live Vaccine market.
Geographical Analysis:
Based on region, the global Varicella Live Vaccine market is segmented into North America, Europe, China, Japan, Southeast Asia India and Other regions (Middle East & Africa, Central & South America). Research analysts have studied government initiatives, changing the political environment, and social scenarios that are likely to contribute to the growth of the regional markets.
Key Players:
The major players that are operating in the global Varicella Live Vaccine market are
Astellas Pharma Inc.
CSL Limited
Emergent BioSolutions, Inc.
GlaxoSmithKline plc
Johnson & Johnson
MedImmune, LLC
Merck & Co., Inc.
Pfizer, Inc.
Sanofi Pasteur
Serum Institute of India Pvt. Ltd.
Bavarian Nordic
Mitsubishi Tanabe Pharma Corporation
Daiichi Sankyo
Biological E
Panacea Biotec
Segment by Type
Monovalent Vaccines
Multivalent Vaccines
Segment by Application
Chicken Pox Immunization
Herpes Zoster Immunization
Measles Immunization
Others
Competitive Landscape:
Factors such as cost analysis, marketing strategy, factor analysis, distributors, sourcing strategy, and industrial chain are all the parts of the global Varicella Live Vaccine market. The report also includes the analysis of the return on investment (ROI) feasibility with the estimated SWOT analysis.
The report covers the following objectives:
• Proliferation and maturation of trade in the global Varicella Live Vaccine market.
• The market share of the global Varicella Live Vaccine market, supply and demand ratio, growth revenue, supply chain analysis, and business overview.
• Current and future market trends that are influencing the growth opportunities and growth rate of the global Varicella Live Vaccine market.
• Feasibility study, new market insights, company profiles, investment return, revenue (value), and consumption (volume) of the global Varicella Live Vaccine market.
1 Varicella Live Vaccine Market Overview
1.1 Varicella Live Vaccine Product Scope
1.2 Varicella Live Vaccine Segment by Type
1.2.1 Global Varicella Live Vaccine Sales by Type (2020-2026)
1.2.2 Monovalent Vaccines
1.2.3 Multivalent Vaccines
1.3 Varicella Live Vaccine Segment by Application
1.3.1 Global Varicella Live Vaccine Sales Comparison by Application (2020-2026)
1.3.2 Chicken Pox Immunization
1.3.3 Herpes Zoster Immunization
1.3.4 Measles Immunization
1.3.5 Others
1.4 Varicella Live Vaccine Market Estimates and Forecasts (2015-2026)
1.4.1 Global Varicella Live Vaccine Sales Growth Rate (2015-2026)
1.4.2 Global Varicella Live Vaccine Revenue and Growth Rate (2015-2026)
1.4.3 Global Varicella Live Vaccine Price Trends (2015-2026)
1.5 Coronavirus Disease 2019 (Covid-19): Varicella Live Vaccine Industry Impact
1.5.1 How the Covid-19 is Affecting the Varicella Live Vaccine Industry
1.5.1.1 Varicella Live Vaccine Business Impact Assessment – Covid-19
1.5.1.2 Supply Chain Challenges
1.5.1.3 COVID-19’s Impact On Crude Oil and Refined Products
1.5.2 Market Trends and Varicella Live Vaccine Potential Opportunities in the COVID-19 Landscape
1.5.3 Measures / Proposal against Covid-19
1.5.3.1 Government Measures to Combat Covid-19 Impact
1.5.3.2 Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact
2 Varicella Live Vaccine Estimate and Forecast by Region
2.1 Global Varicella Live Vaccine Market Size by Region: 2015 VS 2020 VS 2026
2.2 Global Varicella Live Vaccine Retrospective Market Scenario by Region (2015-2020)
2.2.1 Global Varicella Live Vaccine Sales Market Share by Region (2015-2020)
2.2.2 Global Varicella Live Vaccine Revenue Market Share by Region (2015-2020)
2.3 Global Varicella Live Vaccine Market Estimates and Forecasts by Region (2021-2026)
2.3.1 Global Varicella Live Vaccine Sales Estimates and Forecasts by Region (2021-2026)
2.3.2 Global Varicella Live Vaccine Revenue Forecast by Region (2021-2026)
2.4 Geographic Market Analysis: Market Facts & Figures
2.4.1 United States Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.2 Europe Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.3 China Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.4 Japan Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.5 Southeast Asia Varicella Live Vaccine Estimates and Projections (2015-2026)
2.4.6 India Varicella Live Vaccine Estimates and Projections (2015-2026)
3 Global Varicella Live Vaccine Competition Landscape by Players
3.1 Global Top Varicella Live Vaccine Players by Sales (2015-2020)
3.2 Global Top Varicella Live Vaccine Players by Revenue (2015-2020)
3.3 Global Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019)
3.4 Global Varicella Live Vaccine Average Price by Company (2015-2020)
3.5 Manufacturers Varicella Live Vaccine Manufacturing Sites, Area Served, Product Type
3.6 Manufacturers Mergers & Acquisitions, Expansion Plans
3.7 Primary Interviews with Key Varicella Live Vaccine Players (Opinion Leaders)
4 Global Varicella Live Vaccine Market Size by Type
4.1 Global Varicella Live Vaccine Historic Market Review by Type (2015-2020)
4.1.1 Global Varicella Live Vaccine Sales Market Share by Type (2015-2020)
4.1.2 Global Varicella Live Vaccine Revenue Market Share by Type (2015-2020)
4.1.3 Global Varicella Live Vaccine Price by Type (2014-2020)
4.2 Global Varicella Live Vaccine Market Estimates and Forecasts by Type (2021-2026)
4.2.1 Global Varicella Live Vaccine Sales Forecast by Type (2021-2026)
4.2.2 Global Varicella Live Vaccine Revenue Forecast by Type (2021-2026)
4.2.3 Global Varicella Live Vaccine Price Forecast by Type (2021-2026)
5 Global Varicella Live Vaccine Market Size by Application
5.1 Global Varicella Live Vaccine Historic Market Review by Application (2015-2020)
5.1.1 Global Varicella Live Vaccine Sales Market Share by Application (2015-2020)
5.1.2 Global Varicella Live Vaccine Revenue Market Share by Application (2015-2020)
5.1.3 Global Varicella Live Vaccine Price by Application (2015-2020)
5.2 Global Varicella Live Vaccine Market Estimates and Forecasts by Application (2021-2026)
5.2.1 Global Varicella Live Vaccine Sales Forecast by Application (2021-2026)
5.2.2 Global Varicella Live Vaccine Revenue Forecast by Application (2021-2026)
5.2.3 Global Varicella Live Vaccine Price Forecast by Application (2021-2026)
3 North America Varicella Live Vaccine Market Facts & Figures
3.2 North America Varicella Live Vaccine Sales Market Share by Company (2015-2020)
3.3 North America Varicella Live Vaccine Sales Market Share by Type (2015-2020)
3.4 North America Varicella Live Vaccine Sales Market Share by Application (2015-2020)
4 Europe Varicella Live Vaccine Market Facts & Figures
4.2 Europe Varicella Live Vaccine Sales Market Share by Company (2015-2020)
4.3 Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
4.4 Europe Varicella Live Vaccine Sales Market Share by Application (2015-2020)
5 China Varicella Live Vaccine Market Facts & Figures
5.2 China Varicella Live Vaccine Sales Market Share by Company (2015-2020)
5.3 China Varicella Live Vaccine Sales Market Share by Type (2015-2020)
5.4 China Varicella Live Vaccine Sales Market Share by Application (2015-2020)
6 Japan Varicella Live Vaccine Market Facts & Figures
6.2 Japan Varicella Live Vaccine Sales Market Share by Company (2015-2020)
6.3 Japan Varicella Live Vaccine Sales Market Share by Type (2015-2020)
6.4 Japan Varicella Live Vaccine Sales Market Share by Application (2015-2020)
7 Southeast Asia Varicella Live Vaccine Market Facts & Figures
7.2 Southeast Asia Varicella Live Vaccine Sales Market Share by Company (2015-2020)
7.3 Southeast Asia Varicella Live Vaccine Sales Market Share by Type (2015-2020)
7.4 Southeast Asia Varicella Live Vaccine Sales Market Share by Application (2015-2020)
8 India Varicella Live Vaccine Market Facts & Figures
8.2 India Varicella Live Vaccine Sales Market Share by Company (2015-2020)
8.3 India Varicella Live Vaccine Sales Market Share by Type (2015-2020)
8.4 India Varicella Live Vaccine Sales Market Share by Application (2015-2020)
12 Company Profiles and Key Figures in Varicella Live Vaccine Business
12.1 Astellas Pharma Inc.
12.1.1 Astellas Pharma Inc. Varicella Live Vaccine Corporation Information
12.1.2 Astellas Pharma Inc. Varicella Live Vaccine Business Overview and Total Revenue
12.1.3 Astellas Pharma Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.1.4 Astellas Pharma Inc. Varicella Live Vaccine Products Offered
12.1.5 Astellas Pharma Inc. Recent Development
12.2 CSL Limited
12.2.1 CSL Limited Varicella Live Vaccine Corporation Information
12.2.2 CSL Limited Varicella Live Vaccine Business Overview and Total Revenue
12.2.3 CSL Limited Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.2.4 CSL Limited Varicella Live Vaccine Products Offered
12.2.5 CSL Limited Recent Development
12.3 Emergent BioSolutions, Inc.
12.3.1 Emergent BioSolutions, Inc. Varicella Live Vaccine Corporation Information
12.3.2 Emergent BioSolutions, Inc. Varicella Live Vaccine Business Overview and Total Revenue
12.3.3 Emergent BioSolutions, Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.3.4 Emergent BioSolutions, Inc. Varicella Live Vaccine Products Offered
12.3.5 Emergent BioSolutions, Inc. Recent Development
12.4 GlaxoSmithKline plc
12.4.1 GlaxoSmithKline plc Varicella Live Vaccine Corporation Information
12.4.2 GlaxoSmithKline plc Varicella Live Vaccine Business Overview and Total Revenue
12.4.3 GlaxoSmithKline plc Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.4.4 GlaxoSmithKline plc Varicella Live Vaccine Products Offered
12.4.5 GlaxoSmithKline plc Recent Development
12.5 Johnson & Johnson
12.5.1 Johnson & Johnson Varicella Live Vaccine Corporation Information
12.5.2 Johnson & Johnson Varicella Live Vaccine Business Overview and Total Revenue
12.5.3 Johnson & Johnson Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.5.4 Johnson & Johnson Varicella Live Vaccine Products Offered
12.5.5 Johnson & Johnson Recent Development
12.6 MedImmune, LLC
12.6.1 MedImmune, LLC Varicella Live Vaccine Corporation Information
12.6.2 MedImmune, LLC Varicella Live Vaccine Business Overview and Total Revenue
12.6.3 MedImmune, LLC Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.6.4 MedImmune, LLC Varicella Live Vaccine Products Offered
12.6.5 MedImmune, LLC Recent Development
12.7 Merck & Co., Inc.
12.7.1 Merck & Co., Inc. Varicella Live Vaccine Corporation Information
12.7.2 Merck & Co., Inc. Varicella Live Vaccine Business Overview and Total Revenue
12.7.3 Merck & Co., Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.7.4 Merck & Co., Inc. Varicella Live Vaccine Products Offered
12.7.5 Merck & Co., Inc. Recent Development
12.8 Pfizer, Inc.
12.8.1 Pfizer, Inc. Varicella Live Vaccine Corporation Information
12.8.2 Pfizer, Inc. Varicella Live Vaccine Business Overview and Total Revenue
12.8.3 Pfizer, Inc. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.8.4 Pfizer, Inc. Varicella Live Vaccine Products Offered
12.8.5 Pfizer, Inc. Recent Development
12.9 Sanofi Pasteur
12.9.1 Sanofi Pasteur Varicella Live Vaccine Corporation Information
12.9.2 Sanofi Pasteur Varicella Live Vaccine Business Overview and Total Revenue
12.9.3 Sanofi Pasteur Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.9.4 Sanofi Pasteur Varicella Live Vaccine Products Offered
12.9.5 Sanofi Pasteur Recent Development
12.10 Serum Institute of India Pvt. Ltd.
12.10.1 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Corporation Information
12.10.2 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Business Overview and Total Revenue
12.10.3 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.10.4 Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Products Offered
12.10.5 Serum Institute of India Pvt. Ltd. Recent Development
12.11 Bavarian Nordic
12.11.1 Bavarian Nordic Varicella Live Vaccine Corporation Information
12.11.2 Bavarian Nordic Varicella Live Vaccine Business Overview and Total Revenue
12.11.3 Bavarian Nordic Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.11.4 Bavarian Nordic Varicella Live Vaccine Products Offered
12.11.5 Bavarian Nordic Recent Development
12.12 Mitsubishi Tanabe Pharma Corporation
12.12.1 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Corporation Information
12.12.2 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Business Overview and Total Revenue
12.12.3 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.12.4 Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Products Offered
12.12.5 Mitsubishi Tanabe Pharma Corporation Recent Development
12.13 Daiichi Sankyo
12.13.1 Daiichi Sankyo Varicella Live Vaccine Corporation Information
12.13.2 Daiichi Sankyo Varicella Live Vaccine Business Overview and Total Revenue
12.13.3 Daiichi Sankyo Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.13.4 Daiichi Sankyo Varicella Live Vaccine Products Offered
12.13.5 Daiichi Sankyo Recent Development
12.14 Biological E
12.14.1 Biological E Varicella Live Vaccine Corporation Information
12.14.2 Biological E Varicella Live Vaccine Business Overview and Total Revenue
12.14.3 Biological E Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.14.4 Biological E Varicella Live Vaccine Products Offered
12.14.5 Biological E Recent Development
12.15 Panacea Biotec
12.15.1 Panacea Biotec Varicella Live Vaccine Corporation Information
12.15.2 Panacea Biotec Varicella Live Vaccine Business Overview and Total Revenue
12.15.3 Panacea Biotec Varicella Live Vaccine Sales, Revenue and Gross Margin (2015-2020)
12.15.4 Panacea Biotec Varicella Live Vaccine Products Offered
12.15.5 Panacea Biotec Recent Development
13 Varicella Live Vaccine Manufacturing Cost Analysis
13.1 Varicella Live Vaccine Key Raw Materials Analysis
13.1.1 Key Raw Materials
13.1.2 Key Raw Materials Price Trend
13.1.3 Key Suppliers of Raw Materials
13.2 Proportion of Manufacturing Cost Structure
13.3 Manufacturing Process Analysis of Varicella Live Vaccine
13.4 Varicella Live Vaccine Industrial Chain Analysis
14 Marketing Channel, Distributors and Customers
14.1 Marketing Channel
14.2 Varicella Live Vaccine Distributors List
14.3 Varicella Live Vaccine Customers
15 Market Dynamics
15.1 Market Trends
15.2 Opportunities and Drivers
15.3 Challenges
15.4 Porter’s Five Forces Analysis
16 Research Findings and Conclusion
17 Appendix
17.1 Research Methodology
17.1.1 Methodology/Research Approach
17.1.2 Data Source
17.2 Author List
17.3 Disclaimer
Table 1. Global Varicella Live Vaccine Sales (K Units) Growth Rate by Type (2020-2026)
Table 2. Global Varicella Live Vaccine Sales (K Units) Comparison by Application (2020-2026)
Table 3. COVID-19 Impact Global Market: (Four Varicella Live Vaccine Market Size Forecast Scenarios)
Table 4. Opportunities and Trends for Varicella Live Vaccine Players in the COVID-19 Landscape
Table 5. Present Opportunities in China & Elsewhere Due to the Coronavirus Crisis
Table 6. Key Regions/Countries Measures against Covid-19 Impact
Table 7. Proposal for Varicella Live Vaccine Players to Combat Covid-19 Impact
Table 8. Global Market Varicella Live Vaccine Market Size (US$ Million) by Region:2015 VS 2020 &2026
Table 9. Global Varicella Live Vaccine Sales (K Units) by Region (2015-2020)
Table 10. Global Varicella Live Vaccine Sales Market Share by Region (2015-2020)
Table 11. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Region (2015-2020))
Table 12. Global Varicella Live Vaccine Revenue Share by Region (2015-2020)
Table 13. Global Varicella Live Vaccine Sales (K Units) Forecast by Region (2021-2026)
Table 14. Global Varicella Live Vaccine Sales Market Share Forecast by Region (2021-2026)
Table 15. Global Varicella Live Vaccine Revenue (US$ Million) Forecast by Region (2021-2026)
Table 16. Global Varicella Live Vaccine Revenue Share Forecast by Region (2021-2026)
Table 17. Global Varicella Live Vaccine (K Units) of Key Companies (2015-2020)
Table 18. Global Varicella Live Vaccine Sales Share by Company (2015-2020)
Table 19. Global Varicella Live Vaccine Revenue (US$ Million) by Company (2015-2020)
Table 20. Global Varicella Live Vaccine Revenue Share by Company (2015-2020)
Table 21. Global Varicella Live Vaccine by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Varicella Live Vaccine as of 2019)
Table 22. Global Varicella Live Vaccine Average Price (USD/Unit) of Key Company (2015-2020)
Table 23. Manufacturers Varicella Live Vaccine Manufacturing Sites and Area Served
Table 24. Manufacturers Varicella Live Vaccine Product Type
Table 25. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 26. Main Points Interviewed from Key Varicella Live Vaccine Players
Table 27. Global Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 28. Global Varicella Live Vaccine Sales Share by Type (2015-2020)
Table 29. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Type (2015-2020)
Table 30. Global Varicella Live Vaccine Price (K Units) by Type (2015-2020)
Table 31. Global Varicella Live Vaccine Sales Share by Type (2021-2026)
Table 32. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Type (2021-2026)
Table 33. Global Varicella Live Vaccine Revenue Share by Type (2021-2026)
Table 34. Global Varicella Live Vaccine Price (K Units) by Type (2021-2026)
Table 35. Global Varicella Live Vaccine Sales (K Units) by Application (2015-2020)
Table 36. Global Varicella Live Vaccine Sales Share by Application (2015-2020)
Table 37. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Application (2015-2020)
Table 38. Global Varicella Live Vaccine Price (K Units) by Application (2015-2020)
Table 39. Global Varicella Live Vaccine Sales (K Units) by Application (2021-2026)
Table 40. Global Varicella Live Vaccine Sales Share by Application (2021-2026)
Table 41. Global Varicella Live Vaccine Revenue (US$ Million) Market Share by Application (2021-2026)
Table 42. Global Varicella Live Vaccine Revenue Share by Application (2021-2026)
Table 43. Global Varicella Live Vaccine Price (K Units) by Application (2021-2026)
Table 44. United States Varicella Live Vaccine Sales (K Units) by Company (2015-2020)
Table 45. United States Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 46. United States Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 47. United States Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 48. United States Varicella Live Vaccine Sales (K Units) by Application (2015-2020)
Table 49. United States Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 50. Europe Varicella Live Vaccine Sales (K Units) by Company (2015-2020)
Table 51. Europe Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 52. Europe Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 53. Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 54. Europe Varicella Live Vaccine Sales (K Units) by Application (2015-2020)
Table 55. Europe Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 56. China Varicella Live Vaccine Sales (K Units) by Company (2015-2020)
Table 57. China Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 58. China Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 59. China Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 60. China Varicella Live Vaccine Sales (K Units) by Application (2015-2020)
Table 61. China Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 62. Japan Varicella Live Vaccine Sales (K Units) by Company (2015-2020)
Table 63. Japan Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 64. Japan Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 65. Japan Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 66. Japan Varicella Live Vaccine Sales (K Units) by Application (2015-2020)
Table 67. Japan Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 68. Southeast Asia Varicella Live Vaccine Sales (K Units) by Company (2015-2020)
Table 69. Southeast Asia Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 70. Southeast Asia Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 71. Southeast Asia Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 72. Southeast Asia Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 73. Southeast Asia Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 74. India Varicella Live Vaccine Sales (K Units) by Company (2015-2020)
Table 75. India Varicella Live Vaccine Sales Market Share by Company (2015-2020)
Table 76. India Varicella Live Vaccine Sales (K Units) by Type (2015-2020)
Table 77. India Varicella Live Vaccine Sales Market Share by Type (2015-2020)
Table 78. India Varicella Live Vaccine Sales (K Units) by Application (2015-2020)
Table 79. India Varicella Live Vaccine Sales Market Share by Application (2015-2020)
Table 80. Astellas Pharma Inc. Corporation Information
Table 81. Astellas Pharma Inc. Description and Business Overview
Table 82. Astellas Pharma Inc. Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 83. Astellas Pharma Inc. Varicella Live Vaccine Product
Table 84. Astellas Pharma Inc. Recent Development
Table 85. CSL Limited Corporation Information
Table 86. CSL Limited Description and Business Overview
Table 87. CSL Limited Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 88. CSL Limited Varicella Live Vaccine Product
Table 89. CSL Limited Recent Development
Table 90. Emergent BioSolutions, Inc. Corporation Information
Table 91. Emergent BioSolutions, Inc. Description and Business Overview
Table 92. Emergent BioSolutions, Inc. Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 93. Emergent BioSolutions, Inc. Varicella Live Vaccine Product
Table 94. Emergent BioSolutions, Inc. Recent Development
Table 95. GlaxoSmithKline plc Corporation Information
Table 96. GlaxoSmithKline plc Description and Business Overview
Table 97. GlaxoSmithKline plc Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 98. GlaxoSmithKline plc Varicella Live Vaccine Product
Table 99. GlaxoSmithKline plc Recent Development
Table 100. Johnson & Johnson Corporation Information
Table 101. Johnson & Johnson Description and Business Overview
Table 102. Johnson & Johnson Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 103. Johnson & Johnson Varicella Live Vaccine Product
Table 104. Johnson & Johnson Recent Development
Table 105. MedImmune, LLC Corporation Information
Table 106. MedImmune, LLC Description and Business Overview
Table 107. MedImmune, LLC Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 108. MedImmune, LLC Varicella Live Vaccine Product
Table 109. MedImmune, LLC Recent Development
Table 110. Merck & Co., Inc. Corporation Information
Table 111. Merck & Co., Inc. Description and Business Overview
Table 112. Merck & Co., Inc. Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 113. Merck & Co., Inc. Varicella Live Vaccine Product
Table 114. Merck & Co., Inc. Recent Development
Table 115. Pfizer, Inc. Corporation Information
Table 116. Pfizer, Inc. Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 117. Pfizer, Inc. Description and Business Overview
Table 118. Pfizer, Inc. Varicella Live Vaccine Product
Table 119. Pfizer, Inc. Recent Development
Table 120. Sanofi Pasteur Corporation Information
Table 121. Sanofi Pasteur Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 122. Sanofi Pasteur Description and Business Overview
Table 123. Sanofi Pasteur Varicella Live Vaccine Product
Table 124. Sanofi Pasteur Recent Development
Table 125. Serum Institute of India Pvt. Ltd. Corporation Information
Table 126. Serum Institute of India Pvt. Ltd. Description and Business Overview
Table 127. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 128. Serum Institute of India Pvt. Ltd. Varicella Live Vaccine Product
Table 129. Serum Institute of India Pvt. Ltd. Recent Development
Table 130. Bavarian Nordic Corporation Information
Table 131. Bavarian Nordic Description and Business Overview
Table 132. Bavarian Nordic Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 133. Bavarian Nordic Varicella Live Vaccine Product
Table 134. Bavarian Nordic Recent Development
Table 135. Mitsubishi Tanabe Pharma Corporation Corporation Information
Table 136. Mitsubishi Tanabe Pharma Corporation Description and Business Overview
Table 137. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 138. Mitsubishi Tanabe Pharma Corporation Varicella Live Vaccine Product
Table 139. Mitsubishi Tanabe Pharma Corporation Recent Development
Table 140. Daiichi Sankyo Corporation Information
Table 141. Daiichi Sankyo Description and Business Overview
Table 142. Daiichi Sankyo Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 143. Daiichi Sankyo Varicella Live Vaccine Product
Table 144. Daiichi Sankyo Recent Development
Table 145. Biological E Corporation Information
Table 146. Biological E Description and Business Overview
Table 147. Biological E Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table 148. Biological E Varicella Live Vaccine Product
Table 149. Biological E Recent Development
Table . Panacea Biotec Corporation Information
Table . Panacea Biotec Description and Business Overview
Table . Panacea Biotec Varicella Live Vaccine Sales (K Units), Revenue (Million USD), Price (USD/Unit) and Gross Margin (2015-2020)
Table . Panacea Biotec Varicella Live Vaccine Product
Table . Panacea Biotec Recent Development
Table 155. Production Base and Market Concentration Rate of Raw Material
Table 156. Key Suppliers of Raw Materials
Table 157. Varicella Live Vaccine Distributors List
Table 158. Varicella Live Vaccine Customers List
Table 159. Market Key Trends
Table 160. Key Opportunities and Drivers: Impact Analysis (2020-2026)
Table 161. Key Challenges
Table 162. Research Programs/Design for This Report
Table 163. Key Data Information from Secondary Sources
Table 164. Key Data Information from Primary Sources
List of Figures
Figure 1. Varicella Live Vaccine Product Picture
Figure 2. Global Varicella Live Vaccine Sales Market Share by Type in 2020 & 2026
Figure 3. Type I Product Picture
Figure 4. Type II Product Picture
Figure 5. Global Varicella Live Vaccine Market Share by Application in 2020 & 2026
Figure 6. Chicken Pox Immunization Examples
Figure 7. Herpes Zoster Immunization Examples
Figure 8. Measles Immunization Examples
Figure 9. Others Examples
Figure 10. Global Varicella Live Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 11. Global Varicella Live Vaccine Revenue (US$ Million) Growth Rate (2015-2026)
Figure 12. Global Varicella Live Vaccine Price Trends Growth Rate (2015-2026) (USD/Unit)
Figure 13. Global Varicella Live Vaccine Revenue Market Share by Region: 2015 VS 2020
Figure 14. Global Varicella Live Vaccine Revenue Market Share by Region: 2021 VS 2026
Figure 15. United States Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 16. United States Varicella Live Vaccine Sales (K Units) Growth Rate (2015-2026)
Figure 17. Europe Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 18. Europe Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 19. China Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 20. China Varicella Live Vaccine Sales (Million USD) and Growth Rate (2015-2026)
Figure 21. Japan Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 22. Japan Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 23. Southeast Asia Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 24. Southeast Asia Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 25. India Varicella Live Vaccine Revenue (Million USD) Growth Rate (2015-2026)
Figure 26. India Varicella Live Vaccine Sales (Million USD) Growth Rate (2015-2026)
Figure 27. Global 5 Largest Varicella Live Vaccine Players Market Share by Revenue in Varicella Live Vaccine 2015 & 2019
Figure 28. Varicella Live Vaccine Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2015 VS 2019
Figure 29. Global Varicella Live Vaccine Revenue Share by Type (2015-2020)
Figure 30. Global Varicella Live Vaccine Revenue Growth Rate by Type in 2015 & 2019
Figure 31. Global Varicella Live Vaccine Revenue Share by Application (2015-2020)
Figure 32. Global Varicella Live Vaccine Revenue Growth Rate by Application in 2015 & 2019
Figure 33. United States Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 34. United States Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 35. Europe Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 36. Europe Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 37. Europe Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 38. China Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 39. China Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 40. China Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 41. Japan Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 42. Japan Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 43. Japan Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 44. Southeast Asia Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 45. Southeast Asia Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 46. Southeast Asia Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 47. India Varicella Live Vaccine Sales Market Share by Company in 2019
Figure 48. India Varicella Live Vaccine Sales Market Share by Type in 2019
Figure 49. India Varicella Live Vaccine Sales Market Share by Application in 2019
Figure 50. Astellas Pharma Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 51. CSL Limited Total Revenue (US$ Million): 2019 Compared with 2018
Figure 52. Emergent BioSolutions, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 53. GlaxoSmithKline plc Total Revenue (US$ Million): 2019 Compared with 2018
Figure 54. Johnson & Johnson Total Revenue (US$ Million): 2019 Compared with 2018
Figure 55. MedImmune, LLC Total Revenue (US$ Million): 2019 Compared with 2018
Figure 56. Merck & Co., Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 57. Pfizer, Inc. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 58. Sanofi Pasteur Total Revenue (US$ Million): 2019 Compared with 2018
Figure 59. Serum Institute of India Pvt. Ltd. Total Revenue (US$ Million): 2019 Compared with 2018
Figure 60. Bavarian Nordic Total Revenue (US$ Million): 2019 Compared with 2018
Figure 61. Mitsubishi Tanabe Pharma Corporation Total Revenue (US$ Million): 2019 Compared with 2018
Figure 62. Daiichi Sankyo Total Revenue (US$ Million): 2019 Compared with 2018
Figure 63. Biological E Total Revenue (US$ Million): 2019 Compared with 2018
Figure 64. Panacea Biotec Total Revenue (US$ Million): 2019 Compared with 2018
Figure 65. Key Raw Materials Price Trend
Figure 66. Manufacturing Cost Structure of Varicella Live Vaccine
Figure 67. Manufacturing Process Analysis of Varicella Live Vaccine
Figure 68. Varicella Live Vaccine Industrial Chain Analysis
Figure 69. Channels of Distribution
Figure 70. Distributors Profiles
Figure 71. Porter's Five Forces Analysis
Figure 72. Bottom-up and Top-down Approaches for This Report
Figure 73. Data Triangulation
Figure 74. Key Executives Interviewed
水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…- 水痘生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Varicella Live Vaccine Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accu…
- 水痘弱毒生ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The Varicella Attenuated Live Vaccine market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain o…
- 生ワクチンの世界市場レポート2020 A recently published report by QY Research titled Global Live Vaccines Sales Market Report 2020 is designed in a way that helps the readers to acquire a complete knowledge about the overall market scenario and it’s most lucrative sectors. The research report also statistically provides accurate data…
- 麻疹ワクチンの世界市場 2020年：メーカー別、地域別、種類・用途別 Market Overview The global Measles Vaccine market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019. The Measles Vaccine market report…